Legal News

Teva gets Bayer’s cancer drug patent invalidated in UK

Published on: 14 October 2021
Published by: Law360
  • Teva gets Bayer’s cancer drug patent invalidated in UK

Article summary

Law360, London: A London judge on invalidated a Bayer patent for a liver and kidney cancer drug on 8 October 2021, clearing the way for generic-drug maker Teva to release its own version of the product. or take a trial to read the full analysis.

Popular documents